Aptamer Sciences Valuation
| 291650 Stock | KRW 1,816 73.00 3.86% |
At this time, the firm appears to be overvalued. Aptamer Sciences shows a prevailing Real Value of W1644.06 per share. The current price of the firm is W1816.0. Our model approximates the value of Aptamer Sciences from analyzing the firm fundamentals such as Return On Equity of -19.57, shares owned by insiders of 33.00 %, and Operating Margin of (14.32) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Aptamer Sciences' price fluctuation is very steady at this time. Calculation of the real value of Aptamer Sciences is based on 3 months time horizon. Increasing Aptamer Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Aptamer Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aptamer Stock. However, Aptamer Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1816.0 | Real 1644.06 | Hype 1816.0 | Naive 1959.53 |
The real value of Aptamer Stock, also known as its intrinsic value, is the underlying worth of Aptamer Sciences Company, which is reflected in its stock price. It is based on Aptamer Sciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Aptamer Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Aptamer Sciences helps investors to forecast how Aptamer stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aptamer Sciences more accurately as focusing exclusively on Aptamer Sciences' fundamentals will not take into account other important factors: Aptamer Sciences Total Value Analysis
Aptamer Sciences is presently estimated to have takeover price of 169.03 B with market capitalization of 74.03 B, debt of 68.63 M, and cash on hands of 1.01 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Aptamer Sciences fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
169.03 B | 74.03 B | 68.63 M | 1.01 B |
Aptamer Sciences Investor Information
About 33.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Based on the key indicators related to Aptamer Sciences' liquidity, profitability, solvency, and operating efficiency, Aptamer Sciences is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Aptamer Sciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aptamer Sciences has an asset utilization ratio of 0.81 percent. This suggests that the Company is making W0.008096 for each dollar of assets. An increasing asset utilization means that Aptamer Sciences is more efficient with each dollar of assets it utilizes for everyday operations.Aptamer Sciences Ownership Allocation
The market capitalization of Aptamer Sciences is W74.03 Billion. Aptamer Sciences retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Aptamer Sciences Profitability Analysis
The company reported the revenue of 269.28 M. Net Loss for the year was (3.83 B) with profit before overhead, payroll, taxes, and interest of 157.44 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Aptamer Sciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Aptamer Sciences and how it compares across the competition.
About Aptamer Sciences Valuation
The stock valuation mechanism determines Aptamer Sciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Aptamer Sciences. We calculate exposure to Aptamer Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aptamer Sciences's related companies.Aptamer Sciences, Inc., a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. Aptamer Sciences, Inc. was founded in 2011 and is headquartered in Seongnam, South Korea. Aptamer Sciences is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct Aptamer Sciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Aptamer Sciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Aptamer Sciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Aptamer Sciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Aptamer Sciences' revenue streams: Identify Aptamer Sciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Aptamer Sciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Aptamer Sciences' growth potential: Evaluate Aptamer Sciences' management, business model, and growth potential.
- Determine Aptamer Sciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Aptamer Sciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Aptamer Stock analysis
When running Aptamer Sciences' price analysis, check to measure Aptamer Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptamer Sciences is operating at the current time. Most of Aptamer Sciences' value examination focuses on studying past and present price action to predict the probability of Aptamer Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptamer Sciences' price. Additionally, you may evaluate how the addition of Aptamer Sciences to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |